SEAR vs Syria: Hepatitis B surface antigen (HBsAg) prevalence
SEAR
0.2%
in 2024
Syria
2.9%
in 2024
SEAR rank
8th
Syria rank
6th
Hepatitis B surface antigen (HBsAg) prevalence over time
- SEAR
- Syria
How they compare
Syria currently reports 2.9% against 0.2% in SEAR, a difference of 2.7%.
That makes Syria's figure about 14.5 times SEAR's.
Across all 10 years both countries report, Syria has been ahead every year.
SEAR ranks 8th and Syria ranks 6th of 13 groups.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | SEAR | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 3.5% | 3.1% | Syria |
| 2020s | 0.3% | 3.4% | 3.1% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, SEAR or Syria?
- Syria, at 2.9% against 0.2% in SEAR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between SEAR and Syria?
- 2.7%, with Syria ahead.
- How many years of comparable data are there for SEAR and Syria?
- 10 years are reported by both, from 2015 to 2024.
- How do SEAR and Syria rank globally for hepatitis b surface antigen (hbsag) prevalence?
- SEAR ranks 8th and Syria ranks 6th of 13 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.